Literature DB >> 7730143

Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway.

T Fujita1, S Taira, N Kodama, M Matsushita, T Fujita1.   

Abstract

The lectin pathway is a novel pathway for activation of the complement cascade, which is initiated by the binding of mannose-binding protein (MBP) to its carbohydrate ligands. We investigated whether the complement system was activated in vitro by glioma cells through this pathway to the C3 level. MBP was found to bind to all six glioma cell lines tested by using flow cytometric analysis. Binding of a complex of MBP-associated serine protease and MBP was observed in two of the cell lines examined, thereby resulting in C4 consumption. Activation of C3 was hemolytically evaluated in these two lines. C3 consumption was also observed in one. Based on these results, it is likely that recognition by MBP followed by complement activation occurs in certain glioma cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730143      PMCID: PMC5920753          DOI: 10.1111/j.1349-7006.1995.tb03038.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  25 in total

Review 1.  Mannan-binding protein, a complement activating animal lectin.

Authors:  S Thiel
Journal:  Immunopharmacology       Date:  1992 Sep-Oct

2.  Isolation and characterization of a mannan-binding protein from rabbit liver.

Authors:  T Kawasaki; R Etoh; I Yamashina
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

3.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

4.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

5.  Purification and structural analysis of the fourth component of human complement.

Authors:  C Bolotin; S Morris; B Tack; J Prahl
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

6.  Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.

Authors:  N K Cheung; E I Walter; W H Smith-Mensah; W D Ratnoff; M L Tykocinski; M E Medof
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.

Authors:  R A Ezekowitz; M Kuhlman; J E Groopman; R A Byrn
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

8.  The human mannose-binding protein functions as an opsonin.

Authors:  M Kuhlman; K Joiner; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

9.  The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.

Authors:  T Fujita; T Inoue; K Ogawa; K Iida; N Tamura
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.

Authors:  M Matsushita; T Fujita
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 2.  Association of Blood Group Antigen CD59 with Disease.

Authors:  Christof Weinstock
Journal:  Transfus Med Hemother       Date:  2022-01-13       Impact factor: 3.747

Review 3.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 4.  Complement as a Biological Tool to Control Tumor Growth.

Authors:  Paolo Macor; Sara Capolla; Francesco Tedesco
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

Review 5.  The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.

Authors:  Anne Geller; Jun Yan
Journal:  Front Immunol       Date:  2019-05-21       Impact factor: 7.561

6.  DMBT1 expression is down-regulated in breast cancer.

Authors:  P Braidotti; P G Nuciforo; J Mollenhauer; A Poustka; C Pellegrini; A Moro; G Bulfamante; G Coggi; S Bosari; G G Pietra
Journal:  BMC Cancer       Date:  2004-08-09       Impact factor: 4.430

7.  Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

Authors:  Silvio Bandini; Claudia Curcio; Marco Macagno; Elena Quaglino; Maddalena Arigoni; Stefania Lanzardo; Albana Hysi; Giuseppina Barutello; Lorena Consolino; Dario Livio Longo; Piero Musiani; Guido Forni; Manuela Iezzi; Federica Cavallo
Journal:  Oncoimmunology       Date:  2013-09-12       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.